NIO
NIO Inc.
NIO lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
UCAR
U Power Limited
There isn't enough reported data to score UCAR yet.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
UCAR Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
UCAR's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
UCAR PE Valuation
UCAR has no meaningful PE right now: it lost money over the past year.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
UCAR Forward outlook
There aren't enough analyst estimates for UCAR to show an outlook.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO has the edge over UCAR in the latest year-over-year earnings comparison.
UCAR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$728.48 | -$273.46 |
| Q4 2025 | -$451.71 | +$52.23 |
UCAR is still losing money, but far less than before: $728.48 per share over the past year, against $2,761.31 at its worst in late 2022.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over UCAR in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO has the edge over UCAR on profitability, with a higher operating margin.
UCAR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.2M | -17% |
| Q4 2025 | $3.5M | -25% |
| Q2 2025 | $2.7M | +34% |
| Q4 2024 | $4.7M | +74% |
| Q2 2024 | $2M | +596% |
| Q4 2023 | $2.7M | +129% |
| Q4 2022 | $1.2M | +95% |
| Q4 2021 | $601K | +447% |
UCAR's revenue has grown year over year every quarter since late 2022: $2M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -542% | -342 points |
| Q4 2025 | -174% | -83 points |
| Q2 2025 | -98% | +984 points |
| Q4 2024 | -102% | +620 points |
| Q2 2024 | -200% | +361 points |
| Q4 2023 | -92% | +470 points |
| Q2 2023 | -1083% | +11 points |
| Q4 2022 | -722% | +372 points |
UCAR's operating margin was −542% last quarter, down 342 points from the same quarter a year ago.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
UCAR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2022 | -$3.1M | +$3.9M |
| Q4 2021 | -$7M | -$5.2M |
| Q2 2021 | -$7M | -$5.2M |
UCAR and NIO do not have enough comparable growth data to identify a winner.
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has the edge over UCAR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
UCAR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +10% | +2.3K shares |
| 1 year | +59% | +9.3K shares |
UCAR has 25,148 diluted shares, up 59% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | $36M |
| Q4 2021 | — |
| Q2 2021 | — |
| Q4 2020 | — |
| Q2 2020 | — |
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UCAR Net Leverage
UCAR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
UCAR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 20.5 | Oversold |
| Stochastic | 3.2 | Oversold |
UCAR's weekly RSI is 21 (oversold) and its Stochastic is 3 (oversold).
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
UCAR PE vs Consumer Cyclical Sector
UCAR has no meaningful PE right now: it lost money over the past year.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
UCAR has stronger trend alignment. NIO is above 0 of 5 weekly averages versus UCAR above 0 of 4.
UCAR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 17% below |
| 20 week MA | $10.6 | 72% below |
| 50 week MA | $101.2 | 97% below |
| 100 week MA | $366.9 | 99% below |
UCAR is in a downtrend: it's below all four of its weekly moving averages, and 99% below its 100-week average.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO has the edge over UCAR on returns for 2026, with the stronger performance.
UCAR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $156,600.0 | $3,670.0 | -98% |
| 2024 | $3,670.0 | $1,326.0 | -64% |
| 2025 | $1,326.0 | $338.0 | -75% |
| 2026 YTD | $338.0 | $2.93 | -99% |
UCAR has finished every year since 2023 lower, and it's down 99% so far in 2026.